Ruffatti A - Search Results

1

The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies.

Ruffatti A, Tonello M, Favaro M, Del Ross T, Calligaro A, Ruffatti AT, Gervasi MT, Hoxha A. Ruffatti A, et al. Among authors: ruffatti at. Semin Arthritis Rheum. 2021 Feb;51(1):28-35. doi: 10.1016/j.semarthrit.2020.10.001. Epub 2020 Dec 17. Semin Arthritis Rheum. 2021. PMID: 33360227 Review.

2

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.

Hoxha A, Favaro M, Calligaro A, Del Ross T, Ruffatti AT, Infantolino C, Tonello M, Mattia E, Ruffatti A. Hoxha A, et al. Among authors: ruffatti a, ruffatti at. Thromb Haemost. 2020 Jan;120(1):36-43. doi: 10.1055/s-0039-1697665. Epub 2019 Oct 21. Thromb Haemost. 2020. PMID: 31634958

3

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome.

Ruffatti A, Calligaro A, Hoxha A, Trevisanuto D, Ruffatti AT, Gervasi MT, Cuffaro S, Pengo V, Punzi L. Ruffatti A, et al. Among authors: ruffatti at. Arthritis Care Res (Hoboken). 2010 Mar;62(3):302-7. doi: 10.1002/acr.20098. Arthritis Care Res (Hoboken). 2010. PMID: 20391475 Free article.

4

Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study.

Ruffatti A, Gervasi MT, Favaro M, Ruffatti AT, Hoxha A, Punzi L. Ruffatti A, et al. Among authors: ruffatti at. Clin Exp Rheumatol. 2011 May-Jun;29(3):551-4. Epub 2011 Jun 30. Clin Exp Rheumatol. 2011. PMID: 21640048 Clinical Trial.

5

Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation.

Zen M, Tonello M, Favaro M, Del Ross T, Calligaro A, Giollo A, Vesentini F, Gennaio IA, Arru F, Ruffatti A, Doria A. Zen M, et al. Among authors: ruffatti a. Rheumatology (Oxford). 2023 Sep 29:kead517. doi: 10.1093/rheumatology/kead517. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37774001

6

Prevalence and adverse consequences of delayed diagnosis and misdiagnosis in thrombotic antiphospholipid syndrome. An observational cohort study and a review of the literature.

Ruffatti A, Tonello M, Calligaro A, Del Ross T, Favaro M, Zen M, Hoxha A, Alaibac M. Ruffatti A, et al. Clin Rheumatol. 2023 Nov;42(11):3007-3019. doi: 10.1007/s10067-023-06699-1. Epub 2023 Jul 15. Clin Rheumatol. 2023. PMID: 37453028 Free PMC article. Review.

7

Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study.

Ruffatti A, Cerutti A, Tonello M, Favaro M, Del Ross T, Calligaro A, Grava C, Zen M, Hoxha A, Di Salvo G. Ruffatti A, et al. J Perinatol. 2022 Sep;42(9):1161-1168. doi: 10.1038/s41372-022-01431-4. Epub 2022 Jun 18. J Perinatol. 2022. PMID: 35717457

8

High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.

Ruffatti A, Tonello M, Calligaro A, Del Ross T, Favaro M, Zen M, Carletto A, Lotti V, Bertoldo E, Tedesco F, Hoxha A, Biasi D. Ruffatti A, et al. Clin Exp Rheumatol. 2022 Nov;40(11):2088-2096. doi: 10.55563/clinexprheumatol/7cinzu. Epub 2022 Mar 1. Clin Exp Rheumatol. 2022. PMID: 35238757 Free article.

9

Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Hoxha A, Tincani A, Nalli C, Marozio L, Maina A, Espinosa G, Ríos-Garcés R, Cervera R, Carolis S, Monteleone G, Latino O, Udry S, LLurba E, Garrido-Gimenez C, Trespidi L, Gerosa M, Chighizola CB, Rovere-Querini P, Canti V, Mayer-Pickel K, Tabacco S, Arnau A, Trapé J, Ruiz-Hidalgo D, Sos L, Farran-Codina I; EUROAPS Study Group. Alijotas-Reig J, et al. Among authors: ruffatti a. Rheumatology (Oxford). 2021 Dec 1;60(12):5883. doi: 10.1093/rheumatology/keab659. Rheumatology (Oxford). 2021. PMID: 34672326 No abstract available.

10

Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes: A survey of 1075 cases from EUROAPS registry∗.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Pardos-Gea J, Nalli C, Marozio L, Espinosa G, De Carolis S, Latino O, Sebastian U, LLurba E, Trespidi L, Chighizola C, Pengo V, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Tabacco S, Arnau A; EUROAPS Study Group. Alijotas-Reig J, et al. Among authors: ruffatti a. Eur J Anaesthesiol. 2021 Sep 1;38(9):916-922. doi: 10.1097/EJA.0000000000001484. Eur J Anaesthesiol. 2021. PMID: 34397526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page